Back to Results
First PageMeta Content
Alcohols / Ketones / Euphoriants / Drug rehabilitation / Naloxone / Buprenorphine / Methadone / Opioid / Oxycodone / Chemistry / Organic chemistry / Morphinans


Document Date: 2014-07-15 12:03:23

Open Document

File Size: 467,06 KB

Share Result on Facebook

City

New York / Philadelphia / /

Company

LEGAL AND LIABILITY CONSIDERATIONS RESOURCES / Wyatt SA. / /

Country

United States / /

Event

Product Issues / Product Recall / /

Facility

University School / /

IndustryTerm

telephone orders / energy / extended-release product / federal law / care for the presenting symptoms / health insurance plans / /

MedicalCondition

drug addiction / chronic pain / nausea / U.S. epidemic / patient’s disease / common cold preparations / low blood pressure / drowsiness / disorder / poisoning / tachycardia / diarrhea / restlessness / opioid use disorders / acute lung injury / heroin users / disease / cognitive impairment / body aches / fever / Vomiting / pain / runny nose / mild withdrawal symptoms / drug abuse / respiratory depression / abdominal cramps / withdrawal symptoms / /

MedicalTreatment

counseling / resuscitation / pharmacotherapy / drug therapy / /

Organization

Harvard Medical School / American Academy of Addiction Psychiatry / Boston University School of Medicine / BMJ Evidence Centre / Harvard / National Institute on Drug Abuse / Centers for Disease Control and Prevention / Medicare / Intravenous administration / FDA / Substance Abuse and Mental Health Services Administration / Drug Enforcement Administration / /

Person

Ann Internal Med / /

/

Position

physician / addiction specialist / /

Product

OF OPIOID / symptoms / syndromes / NALOXONE / Narcan / fentanyl / /

ProvinceOrState

Illinois / New York / Massachusetts / /

PublishedMedium

British Medical Journal / /

URL

www.prescribetoprevent / http /

SocialTag